封面
市場調查報告書
商品編碼
1458737

Sanger定序2024 年全球市場報告

Sanger Sequencing Global Market Report 2024

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

Sanger定序市場規模預計在未來幾年將快速成長。到 2028 年,將以 17.8% 的年複合成長率(CAGR)成長至 53 億美元。預測期內的預期成長是由臨床基因組學整合程度的提高、農業基因組學應用的擴大、對藥物安全性和藥物基因組學的日益關注、產前和新生兒篩檢的使用增加以及環境DNA 分析的採用增加等因素推動的。這段時期的主要趨勢包括技術進步、對次世代定序技術的需求增加、臨床診斷應用的擴大、基因組學研究投資的增加以及基因組學在個人化醫療中的擴大使用。

預計遺傳疾病數量的增加可能是近期Sanger定序市場擴張的驅動力。遺傳疾病(遺傳性疾病)是由個體DNA(攜帶遺傳訊息的遺傳物質)異常或突變引起的。Sanger定序透過準確確定特定基因或 DNA 區域內的核苷酸(DNA 的組成部分)序列,在診斷遺傳性疾病中發揮重要作用。例如,美國政府美國遺傳和罕見疾病資訊中心 (GARD) 的資料顯示,到 2024 年 2 月,大約有 7,000 種已知的罕見遺傳疾病;大約十分之一,約 3000 萬人受到影響。因此,遺傳疾病的擴散成為推動Sanger定序市場成長的催化劑。

Sanger定序市場的主要參與者正在投資先進系統的開發,以推動收益成長。這些先進的系統專為提高吞吐量而設計,允許同時處理多個樣品。例如,美國酵素及相關產品專業製造商 Promega 公司於 2021 年 10 月推出了 ProDye Terminator 定序系統。該系統與所有毛細管電泳 (CE) 平台相容,包括緊湊型桌上型 Spectrum Compact CE 系統。該系統允許實驗室在各種規模的實驗室的任何 CE 儀器上進行Sanger定序。 ProDye Terminator 定序系統利用專有的熱穩定性 DNA聚合酵素,可部署在各種儀器上,包括 Spectrum Compact CE 系統、SeqStudio 遺傳分析儀和 Applied Biosystems 遺傳分析儀。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長,2023-2028、2033

第6章市場區隔

  • 全球Sanger定序市場,依定序細分、實際與預測,2018-2023、2023-2028、2033
  • 霰彈槍定序
  • 標靶基因序列測定序
  • 其他序列
  • 全球Sanger定序市場,依實驗室細分,實際與預測,2018-2023、2023-2028、2033
  • 濕實驗室
  • 乾燥實驗室
  • 全球Sanger定序市場,依研究、實際及預測細分,2018-2023、2023-2028、2033
  • 公司內部
  • 外包
  • 全球Sanger定序市場,依應用細分、實際與預測,2018-2023、2023-2028、2033
  • 診斷
  • 生物標記和癌症
  • 生殖健康
  • 個人化醫療
  • 法醫學
  • 其他應用
  • 全球Sanger定序市場,依最終用戶細分,實際與預測,2018-2023、2023-2028、2033
  • 學術的
  • 政府研究所
  • 製藥公司
  • 生技公司
  • 醫院
  • 診所

第 7 章 區域/國家分析

  • 全球Sanger定序市場、地區、實際與預測,2018-2023、2023-2028、2033
  • 全球Sanger定序市場,依國家、實際與預測,2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • Sanger定序市場競爭格局
  • Sanger定序市場公司概況
    • Hoffmann-La Roche
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Eurofins Scientific
    • Illumina Inc.

第31章 其他大型創新企業

  • Beckman Coulter
  • PerkinElmer Inc.
  • BGI Group
  • LGC Limited
  • GenScript
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • GENEWIZ Inc.
  • Quintara Biosciences
  • CeMIA SA
  • Source BioScience
  • Microsynth AG
  • Fasteris SA
  • GenHunter Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r16719

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.75 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth observed during the historical period can be attributed to several factors, including heightened demand for research, expanding applications in medical diagnostics, growing pharmaceutical development activities, increased utilization in agriculture, rising demand for forensic analysis, enhanced discovery of biomarkers, and growing studies in genetic evolution.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.30 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth anticipated in the forecast period is driven by several factors, including the increasing integration of clinical genomics, expanded applications in agricultural genomics, heightened focus on drug safety and pharmacogenomics, rising utilization of prenatal and newborn screening, and increased adoption of environmental DNA analysis. Major trends expected during this period include technological advancements, a growing demand for next-generation sequencing technologies, expanding applications in clinical diagnostics, increased investments in genomics research, and the widening use of genomics in personalized medicine.

The projected increase in genetic illnesses is set to drive the expansion of the Sanger sequencing market in the foreseeable future. Genetic illnesses, or genetic disorders, stem from abnormalities or mutations in an individual's DNA, the genetic material responsible for carrying hereditary information. Sanger sequencing plays a crucial role in diagnosing genetic illnesses by precisely determining the sequence of nucleotides (the DNA building blocks) within a specific gene or DNA region. For instance, data from the Genetic Rare Diseases Information Center (GARD), a US-based government agency, revealed approximately 7,000 known rare genetic diseases by February 2024, affecting approximately 1 in 10 individuals or around 30 million people in the United States during 2020-2021. Consequently, the surge in genetic illnesses acts as a catalyst propelling the growth of the Sanger sequencing market.

Major players within the Sanger sequencing market are investing in the development of advanced systems to drive revenue growth. These advanced systems are engineered to accommodate higher throughput, enabling the simultaneous processing of multiple samples. For example, in October 2021, Promega Corporation, a US-based manufacturer specializing in enzymes and related products, introduced the ProDye Terminator Sequencing System. This system is compatible with all capillary electrophoresis (CE) platforms, including the compact benchtop Spectrum Compact CE System. It enables research laboratories to conduct Sanger sequencing on any CE instrument, catering to a range of laboratory sizes. Leveraging a proprietary thermostable DNA polymerase, the ProDye Terminator Sequencing System can be deployed on various instruments such as the Spectrum Compact CE System, SeqStudio Genetic Analyzers, and Applied Biosystems Genetic Analyzers.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2023. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Sanger Sequencing Market Size and Growth

  • 5.1. Global Sanger Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Sanger Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Sanger Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Illumina Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking

33. Global Sanger Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sanger Sequencing Market

35. Sanger Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Sanger Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer